Purchase Order 75N90019P00156
Award Date 1/4/19
Potential Completion Date 1/30/21
Potential Value $148K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Warren, NJ 07059, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed-price purchase order worth $138,446.36 to Bioarray Solutions Ltd, a for-profit manufacturer, to provide transfusion medicine reagents. This contract was not set aside and was awarded on a sole-source basis, as Bioarray Solutions is the sole manufacturer and trademark holder for the proprietary reagents required for the government-owned BioArray Imaging System used for red blood cell...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Bioarray Solutions LTD, a for-profit manufacturer, to provide bioarray reagents. The contract has a ceiling value of $40,660.58 and a period of performance ending on January 31, 2019. This award is not set aside and is one of multiple prime contracts that Bioarray Solutions has received from the NIH Clinical Center in recent years to provide a range of products and services in...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Bioarray Solutions Ltd., a for-profit manufacturer registered in SAM.gov. The contract, with a ceiling value of $79,504.00, is for the provision of laboratory equipment and supplies, and has an ultimate completion date of September 21, 2023. The contract was not set aside for any specific business type. Bioarray Solutions has been awarded multiple prime contracts from the NIH...
- The National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., to procure various reagents and supplies needed for clinical patient care testing by the Department of Laboratory Medicine, Hematology Service. The $34,845.94 contract, awarded on November 1, 2024, is for proprietary reagents and consumables specifically designed for use with the existing instruments at the Clinical...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order for $16,566.11 to Immucor Inc. to fulfill a requirement for reagents. The contract has no set-aside designation and is to be completed by September 30, 2024. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. This award positions Immucor to directly supply specialized...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $198,597.49 firm-fixed-price purchase order contract to Life Technologies Corporation, a for-profit manufacturer, to supply specialized reagents and disposables to support the NIH's cellular therapy research and treatment programs. The contract is for a base year with three option years, providing reagents and supplies to enable the processing of approximately 100 cellular therapy...
- This is a $14,557.30 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a for-profit manufacturer of blood transfusion and transplantation diagnostics. The contract is for the delivery of unspecified in vitro diagnostic products, reagents, and test kits to support the blood typing, compatibility testing, and other blood banking operations required by the NIH Clinical Center. The contract does not have a set-aside...
- This is a $75,025.40 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics and laboratory testing solutions. The contract is for the supply of reagents and supplies required for molecular patient care testing, with a period of performance ending on February 8, 2022. The contract does not have a set-aside designation. Biomerieux Inc. is the prime contractor, and there is no information...
- The National Institutes of Health (NIH) Clinical Center awarded a $22.8K purchase order to Mission Bio, Inc. on August 26, 2025, for the delivery of Mission Bio Reagent Kits. This firm fixed-price contract, which carries no set-aside designation, is scheduled for completion by August 25, 2026, with performance taking place at Mission Bio's facility in South San Francisco, California. The award represents a continuation of the NIH Clinical Center's relationship with Mission Bio, a specialized...
- Becton, Dickinson and Company, operating through its BD Diagnostic Systems division, was awarded a $170,000 firm-fixed-price purchase order contract by the Department of Health and Human Services National Institutes of Health Clinical Center. The contract is for the supply of various reagents, blood culture, and MGIT testing products to support the detection of pathogens that cause infections in NIH patients. The contract has a base year from April 2021 to April 2022, with one option year to...